Denis Kessler
Insider
First SEC filing: July 30, 2007 · Latest: Feb. 14, 2008
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | IVZ | M | 10,930 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 15, 2023 | IVZ | A | 12,820 | · | · | 12,820 Direct | · | Acquired | (price as of 2026-10-02) |
| May 15, 2023 | IVZ | M | 10,930 | · | · | 92,870 Direct | +13.34% | Acquired | (price as of 2026-10-02) |
| May 15, 2022 | IVZ | A | 10,930 | · | · | 10,930 Direct | · | Acquired | (price as of 2026-10-02) |
| May 15, 2022 | IVZ | M | 5,807 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 15, 2022 | IVZ | M | 5,807 | · | · | 81,940 Direct | +7.63% | Acquired | (price as of 2026-10-02) |
| April 29, 2022 | IVZ | M | 1,311 | · | · | 5,807 Direct | -18.42% | Disposed | (price as of 2026-10-02) |
| April 29, 2022 | IVZ | M | 1,311 | · | · | 76,133 Direct | +1.75% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2022 | IVZ | M | 1,744 | · | · | 7,118 Direct | -19.68% | Disposed | (price as of 2026-10-02) |
| Jan. 27, 2022 | IVZ | M | 1,744 | · | · | 74,822 Direct | +2.39% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2021 | IVZ | M | 2,719 | · | · | 8,862 Direct | -23.48% | Disposed | (price as of 2026-10-02) |
| Oct. 28, 2021 | IVZ | M | 2,719 | $25.49 | $69,307 | 73,078 Direct | +3.86% | Acquired | 20.3% (price as of 2026-10-02) |
| July 29, 2021 | IVZ | M | 3,419 | · | · | 11,581 Direct | -22.79% | Disposed | (price as of 2026-10-02) |
| July 29, 2021 | IVZ | M | 3,419 | $24.35 | $83,253 | 70,359 Direct | +5.11% | Acquired | 25.9% (price as of 2026-10-02) |
| May 15, 2021 | IVZ | A | 5,807 | · | · | 15,000 Direct | +63.17% | Acquired | (price as of 2026-10-02) |
| April 29, 2021 | IVZ | A | 1,311 | · | · | 9,193 Direct | +16.63% | Acquired | (price as of 2026-10-02) |
| April 24, 2021 | IVZ | M | 4,647 | · | · | 7,882 Direct | -37.09% | Disposed | (price as of 2026-10-02) |
| April 24, 2021 | IVZ | M | 4,647 | $26.51 | $123,192 | 66,940 Direct | +7.46% | Acquired | 15.7% (price as of 2026-10-02) |
| Jan. 27, 2021 | IVZ | A | 1,744 | · | · | 12,529 Direct | +16.17% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2020 | IVZ | A | 2,719 | · | · | 2,719 Direct | · | Acquired | (price as of 2026-10-02) |
| July 29, 2020 | IVZ | A | 3,419 | · | · | 3,419 Direct | · | Acquired | (price as of 2026-10-02) |
| April 24, 2020 | IVZ | A | 4,647 | · | · | 4,647 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2020 | IVZ | A | 2,056 | · | · | 62,293 Direct | +3.41% | Acquired | (price as of 2026-10-02) |
| Oct. 25, 2019 | IVZ | A | 2,126 | · | · | 60,237 Direct | +3.66% | Acquired | (price as of 2026-10-02) |
| July 26, 2019 | IVZ | A | 1,848 | · | · | 58,111 Direct | +3.28% | Acquired | (price as of 2026-10-02) |
| April 26, 2019 | IVZ | A | 1,665 | · | · | 56,263 Direct | +3.05% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2019 | IVZ | A | 1,989 | · | · | 54,598 Direct | +3.78% | Acquired | (price as of 2026-10-02) |
| Oct. 19, 2018 | IVZ | A | 1,649 | · | · | 52,609 Direct | +3.24% | Acquired | (price as of 2026-10-02) |
| July 27, 2018 | IVZ | A | 1,395 | · | · | 50,960 Direct | +2.81% | Acquired | (price as of 2026-10-02) |
| April 27, 2018 | IVZ | A | 1,225 | · | · | 49,565 Direct | +2.53% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2018 | IVZ | A | 1,006 | · | · | 48,340 Direct | +2.13% | Acquired | (price as of 2026-10-02) |
| Oct. 26, 2017 | IVZ | A | 982 | · | · | 47,334 Direct | +2.12% | Acquired | (price as of 2026-10-02) |
| July 28, 2017 | IVZ | A | 1,055 | · | · | 46,352 Direct | +2.33% | Acquired | (price as of 2026-10-02) |
| April 28, 2017 | IVZ | A | 1,100 | · | · | 45,297 Direct | +2.49% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2017 | IVZ | A | 1,228 | · | · | 44,197 Direct | +2.86% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2016 | IVZ | A | 1,270 | · | · | 42,969 Direct | +3.05% | Acquired | (price as of 2026-10-02) |
| July 29, 2016 | IVZ | A | 1,242 | · | · | 41,699 Direct | +3.07% | Acquired | (price as of 2026-10-02) |
| April 29, 2016 | IVZ | A | 1,168 | · | · | 40,457 Direct | +2.97% | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2016 | IVZ | A | 1,211 | · | · | 39,289 Direct | +3.18% | Acquired | (price as of 2026-10-02) |
| Oct. 30, 2015 | IVZ | A | 1,092 | · | · | 38,078 Direct | +2.95% | Acquired | (price as of 2026-10-02) |
| July 31, 2015 | IVZ | A | 939 | · | · | 36,986 Direct | +2.60% | Acquired | (price as of 2026-10-02) |
| May 1, 2015 | IVZ | A | 871 | · | · | 36,047 Direct | +2.48% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2015 | IVZ | A | 986 | · | · | 35,176 Direct | +2.88% | Acquired | (price as of 2026-10-02) |
| Oct. 31, 2014 | IVZ | A | 895 | · | · | 34,190 Direct | +2.69% | Acquired | (price as of 2026-10-02) |
| Aug. 1, 2014 | IVZ | A | 958 | · | · | 33,295 Direct | +2.96% | Acquired | (price as of 2026-10-02) |
| May 2, 2014 | IVZ | A | 1,008 | · | · | 32,337 Direct | +3.22% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2014 | IVZ | A | 714 | · | · | 31,329 Direct | +2.33% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | IVZ | A | 701 | · | · | 30,615 Direct | +2.34% | Acquired | (price as of 2026-10-02) |
| Aug. 1, 2013 | IVZ | A | 718 | · | · | 29,914 Direct | +2.46% | Acquired | (price as of 2026-10-02) |
| May 1, 2013 | IVZ | A | 755 | · | · | 29,196 Direct | +2.65% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2013 | IVZ | A | 855 | · | · | 28,441 Direct | +3.10% | Acquired | (price as of 2026-10-02) |
| Nov. 2, 2012 | IVZ | A | 973 | · | · | 27,586 Direct | +3.66% | Acquired | (price as of 2026-10-02) |
| July 27, 2012 | IVZ | A | 1,073 | · | · | 26,613 Direct | +4.20% | Acquired | (price as of 2026-10-02) |
| April 27, 2012 | IVZ | A | 946 | · | · | 25,540 Direct | +3.85% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2012 | IVZ | A | 1,033 | · | · | 24,594 Direct | +4.38% | Acquired | (price as of 2026-10-02) |
| Oct. 25, 2011 | IVZ | A | 1,263 | · | · | 23,561 Direct | +5.66% | Acquired | (price as of 2026-10-02) |
| July 27, 2011 | IVZ | A | 1,066 | · | · | 22,298 Direct | +5.02% | Acquired | (price as of 2026-10-02) |
| April 28, 2011 | IVZ | A | 951 | · | · | 21,232 Direct | +4.69% | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2011 | IVZ | A | 963 | · | · | 20,281 Direct | +4.98% | Acquired | (price as of 2026-10-02) |
| Oct. 26, 2010 | IVZ | A | 1,062 | · | · | 19,318 Direct | +5.82% | Acquired | (price as of 2026-10-02) |
| July 28, 2010 | IVZ | A | 1,228 | · | · | 18,256 Direct | +7.21% | Acquired | (price as of 2026-10-02) |
| April 29, 2010 | IVZ | A | 1,003 | · | · | 17,028 Direct | +6.26% | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2010 | IVZ | A | 906 | · | · | 16,025 Direct | +5.99% | Acquired | (price as of 2026-10-02) |
| Oct. 21, 2009 | IVZ | A | 767 | · | · | 15,119 Direct | +5.34% | Acquired | (price as of 2026-10-02) |
| July 28, 2009 | IVZ | A | 916 | · | · | 14,352 Direct | +6.82% | Acquired | (price as of 2026-10-02) |
| April 24, 2009 | IVZ | A | 1,192 | · | · | 13,436 Direct | +9.74% | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2009 | IVZ | A | 1,401 | · | · | 12,244 Direct | +12.92% | Acquired | (price as of 2026-10-02) |
| Oct. 30, 2008 | IVZ | A | 1,217 | · | · | 10,843 Direct | +12.64% | Acquired | (price as of 2026-10-02) |
| May 16, 2008 | IVZ | A | 714 | · | · | 8,839 Direct | +8.79% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2008 | IVZ | A | 1,593 | · | · | 8,125 Direct | +24.39% | Acquired | (price as of 2026-10-02) |
| July 25, 1998 | IVZ | A | 787 | · | · | 9,626 Direct | +8.90% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 15, 2023 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 10,930 | Disposed |
| May 15, 2023 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 12,820 | Acquired |
| May 15, 2022 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 10,930 | Acquired |
| May 15, 2022 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 5,807 | Disposed |
| April 29, 2022 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 1,311 | Disposed |
| Jan. 27, 2022 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 1,744 | Disposed |
| Oct. 28, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 2,719 | Disposed |
| July 29, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 3,419 | Disposed |
| May 15, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 5,807 | Acquired |
| April 29, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 1,311 | Acquired |
| April 24, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 4,647 | Disposed |
| Jan. 27, 2021 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 1,744 | Acquired |
| Oct. 28, 2020 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 2,719 | Acquired |
| July 29, 2020 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 3,419 | Acquired |
| April 24, 2020 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 4,647 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 30, 2007 | IVZ | Ordinary Shares, par value $0.10 per share | 13,064 | Direct |